At the experiment end of 30 weeks, all mice with the Tigar+/+ or Tigar+/- genotype (11/11) developed ESCC, but only 82% (9/11) of Tigar-/- mice had ESCC at the same time (Figure S2D). The gene discussed is TIGAR; the disease is esophageal squamous cell carcinoma.